Narr, A. (2023). Classification of acute myeloid leukemia as a ferroptosis-sensitive malignancy suggesting the development of arsenic trioxide mediated ferroptosis-inducing combination therapies.
Chicago Style (17th ed.) CitationNarr, Andreas. Classification of Acute Myeloid Leukemia as a Ferroptosis-sensitive Malignancy Suggesting the Development of Arsenic Trioxide Mediated Ferroptosis-inducing Combination Therapies. Heidelberg, 2023.
MLA (9th ed.) CitationNarr, Andreas. Classification of Acute Myeloid Leukemia as a Ferroptosis-sensitive Malignancy Suggesting the Development of Arsenic Trioxide Mediated Ferroptosis-inducing Combination Therapies. 2023.
Warning: These citations may not always be 100% accurate.